Emergent BioSolutions
EBS
$3.16
Share price
-7.06%
Change (1 day)
-89.71%
Change (1 year)
Categories
Number of shares outstanding for Emergent BioSolutions (EBS)
Number of shares outstanding as of October 2023 : 50,200,000
According to Emergent BioSolutions 's latest financial reports and stock price the company's current number of shares outstanding is 50,200,000. At the end of 2023 the company had 50,200,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Emergent BioSolutions from 2004 to 2023
Shares Outstanding at the end of each year
| Year | Shares Outstanding | Change |
|---|---|---|
| 2023 | 50.2 M | 0.6% |
| 2022 | 49.9 M | -6.73% |
| 2021 | 53.5 M | 0.75% |
| 2020 | 53.1 M | 2.71% |
| 2019 | 51.7 M | 1.57% |
| 2018 | 50.9 M | 14.98% |
| 2017 | 44.26 M | 9.26% |
| 2016 | 40.51 M | 3.62% |
| 2015 | 39.1 M | 4.02% |
| 2014 | 37.59 M | 3.23% |
| 2013 | 36.41 M | 1.46% |
| 2012 | 35.89 M | 0.1% |
| 2011 | 35.85 M | 14.55% |
| 2010 | 31.3 M | 2.61% |
| 2009 | 30.5 M | 2.31% |
| 2008 | 29.81 M | 0.27% |
| 2007 | 29.73 M | 32.83% |
| 2006 | 22.38 M | 12.34% |
| 2005 | 19.93 M | 5.34% |
| 2004 | 18.91 M |
Shares Outstanding for similar companies or competitors
| Company | Shares Outstanding | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | 5,634,000,000 | 11,123.11% | 🇺🇸 USA |
 Merck MRK | 2,538,000,000 | 4,955.78% | 🇺🇸 USA |
 GlaxoSmithKline GSK | 2,022,000,000 | 3,927.89% | 🇬🇧 UK |
 Soligenix SNGX | 2,914,929 | -94.19% | 🇺🇸 USA |
 SIGA Technologies SIGA | 72,197,038 | 43.82% | 🇺🇸 USA |
 Celldex Therapeutics CLDX | 47,214,000 | -5.95% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | 1,115,000,000 | 2,121.12% | 🇮🇱 Israel |